Search

Your search keyword '"Mollmann, H."' showing total 5 results
Start Over "Mollmann, H." Publication Year Range Last 10 years Publication Type Magazines
5 results on '"Mollmann, H."'

1. Gender-specific Evaluation of Symptom Awareness in Female Versus Male Patients with Severe Aortic Stenosis.

Subjects
SEX factors in disease, HEART valve diseases, AORTIC valve insufficiency, AORTIC valve diseases, AORTIC stenosis, HEART valve prosthesis implantation, MYOCARDIAL infarction, CHEST pain
Abstract

The article discusses a clinical trial, NCT06677528, focusing on comparing symptom awareness and disease perception between male and female patients with severe aortic stenosis. The study aims to address the underdiagnosis of aortic stenosis, particularly in women, and the gender-specific differences in symptom perception. It highlights the importance of early detection and treatment of aortic valve stenosis, emphasizing the need for increased awareness and regular screenings, especially for asymptomatic individuals. The trial is observational, with a prospective cohort design, and aims to enroll 800 participants in Germany, focusing on patients undergoing aortic valve replacement procedures. [Extracted from the article]

Published
2024

2. A Prospective, Multicenter, Open-label, Randomized, Comparative Clinical Trial to Verify the Effectiveness, Safety, and Cost-effectiveness of AI-Gatekeeper, a Multimodal AI Software, in Assisting the Screening of Coronary Artery Stenosis.

Subjects
CORONARY artery stenosis, CHEST pain, MYOCARDIAL infarction, MEDICAL screening, HEART disease diagnosis, BLOOD testing, CLINICAL trials, MACHINE learning, STRESS echocardiography
Abstract

A clinical trial, NCT06178900, is currently underway to assess the effectiveness, safety, and cost-effectiveness of AI-Gatekeeper software in diagnosing coronary artery disease (CAD). The software utilizes AI technology to predict the presence of coronary artery stenosis by analyzing various clinical risk factors and baseline blood tests, as well as diagnostic tests such as chest X-rays, electrocardiograms, and echocardiograms. The trial aims to evaluate the accuracy of the software, compare healthcare costs, and assess changes in angina symptoms. Coronary artery disease is a major global cause of death, and this trial seeks to enhance diagnostic methods and reduce unnecessary procedures and expenses. The trial is not yet recruiting participants, but it is expected to enroll 450 individuals and conclude by April 2025. It is being conducted by Yonsei University in collaboration with the Korea Medical Device Development Fund. [Extracted from the article]

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results